Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Building Safeguards for Genetically Engineered Microbes

Air Force COVID-19 Medical Transport: Portable Biocontainment Care Module

by Global Biodefense Staff June 4, 2020, 12:42 pm
How is Used PPE Disposed of During the Coronavirus Pandemic?

by Carly Fletcher, Manchester Metropolitan University May 12, 2020, 6:12 am
AFRL Aircraft Decontamination Team Ramps Up Battle Against COVID-19

by Global Biodefense Staff April 29, 2020, 2:00 pm
Washington State Recalls 12,000 COVID-19 Test Kits Due to Possible Contamination

by Global Biodefense Staff April 19, 2020, 7:47 pm
CDC Coronavirus Test Kit Failure Due to Contamination

by Global Biodefense Staff April 19, 2020, 6:17 pm
Global Health Security Partnerships: Expanding and Improving Public Health Laboratory Strategies and System

by Global Biodefense Staff March 11, 2020, 8:58 am
EPA Releases List of Disinfectants to Use Against COVID-19

by Global Biodefense Staff March 5, 2020, 5:11 pm
Whistleblower Complaint Details Chaotic Handling of U.S. Quarantine Logistics, Potential Community Exposures

by Global Biodefense Staff February 27, 2020, 1:59 pm
The Future Biosecurity Implications of Thousands of Samples Taken During Outbreaks

by Global Biodefense Staff January 10, 2020, 10:47 am
CDC Approves Partial Resumption of USAMRIID Select Agent Research

by Global Biodefense Staff November 23, 2019, 3:07 pm
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
Biosafety Levels in Laboratories – What is the Difference?

by Frankie Catalfumo September 22, 2019, 3:22 pm
Explosion Confirmed at Russian Lab Storing Smallpox, Ebola

by Global Biodefense Staff September 21, 2019, 12:00 pm
DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight

by Stephanie Lizotte September 9, 2019, 3:23 pm
How Does USAMRIID Shut Down Impact Nation’s Bioterrorism Laboratory Response Network?

by Stephanie Lizotte August 13, 2019, 10:00 am

Congratulations. You've reached the end of the internet.

Biosafety

Building Safeguards for Genetically Engineered Microbes

Inside the Lab: How Do Coronavirus Researchers Avoid Catching COVID-19?

Draft Policy Issued for Large Animal Outdoor Containment Select Agent Studies

Validated Methods for Removing Select Agent Samples from BSL-3 Labs

Air Force COVID-19 Medical Transport: Portable Biocontainment Care Module

How is Used PPE Disposed of During the Coronavirus Pandemic?

AFRL Aircraft Decontamination Team Ramps Up Battle Against COVID-19

Washington State Recalls 12,000 COVID-19 Test Kits Due to Possible Contamination

CDC Coronavirus Test Kit Failure Due to Contamination

Global Health Security Partnerships: Expanding and Improving Public Health Laboratory Strategies and System

EPA Releases List of Disinfectants to Use Against COVID-19

Whistleblower Complaint Details Chaotic Handling of U.S. Quarantine Logistics, Potential Community Exposures

The Future Biosecurity Implications of Thousands of Samples Taken During Outbreaks

CDC Approves Partial Resumption of USAMRIID Select Agent Research

Biosafety Levels in Laboratories – What is the Difference?

Explosion Confirmed at Russian Lab Storing Smallpox, Ebola

DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight

How Does USAMRIID Shut Down Impact Nation’s Bioterrorism Laboratory Response Network?

Biodefense Headlines – 21 January 2021

For Some, GI Tract May Be Vulnerable to COVID-19 Infection

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles